This is a combined synopsis/solicitation for commercial items prepared in accordance with Revolutionary Federal Acquisition Regulation Overhaul (RFO) Subpart 12.202, Publicizing. The Centers for Disea... This is a combined synopsis/solicitation for commercial items prepared in accordance with Revolutionary Federal Acquisition Regulation Overhaul (RFO) Subpart 12.202, Publicizing. The Centers for Disease Control and Prevention (CDC) Office of Acquisition Services has requirement to contract on behalf of the National Center for HIV, Viral Hepatitis, STD, and Tuberculosis and Division of HIV Prevention for services to provide a multi-jurisdictional formative research study to support expansion of self-collection-based viral load monitoring into additional Ending the HIV Epidemic initiative. Please refer to the attached RFQ included with this notice for the full description of the required tasks under this procurement. The solicitation number for this procurement is 75D301-26-Q-79162 and is being issued as a Request for Quote (RFQ) utilizing the procedures at RFO Part 12, Acquisition of Commercial Products and Commercial Services. Additional procurement details are as follows: Contract type: Firm-Fixed-Price. This procurement will be initially awarded as a purchase order and becomes a binding contract upon acceptance by the quoter or performance by the quoter against the purchase order, whicever occurs sooner. Applicable North American Industry Classification System Code (NAICS): 541720, Research and Development in the Social Sciences and Humanities. This NAICS has a small business size standard of $28.0M. PSC Code: B599, Special Studies/Analysis – Other Competition Type: This RFQ is being issued on an unrestricted basis Period of Performance: August 1, 2026 to July 31, 2027 Place of Performance: Contractor’s facility RFQ Questions Submittal Due Date: Tuesday, July 28 at 4:00 p.m. ET. Quote Due Date: Thursday, July 29 at 10:00 a.m. ET Quote Submittal Government Point of Contact: Please submit your quote to the following Contracting Officer. A confirmation of receipt will be provided. Serina Allingham Contracting Officer (770) 488-4602 xog9@cdc.gov Applicable RFO and Health and Human Services Acquisition Regulation (HHSAR) clauses and provisions: The quoters retain responsbility for ensuring familiarity with the applicable provisions and clauses for the subject procurement. This procurement will make use of all applicable commercial provisions and clauses. Clauses and provisions may be accessed at the following links: https://www.acquisition.gov/far-overhaul/far-part-deviation-guide https://www.acquisition.gov/hhsar The following RFO provision and clause are applicable to this procurement: RFO Provision 52.212-1, Instructions to Offerors-Commercial Products and Commercial Services, applies to this acquisition. RFO Clause 52.212-4, Contract Terms and Conditions-Commercial Products and Commercial Services Quoter Eligibility: To be eligible to receive an award resulting from this solicitation, the successful awardee must be registered in the System for Award Management at the time of quote submission. The following is being provided with this notice: Attachment 0001 - RFQ 75D301-26-Q-79162 Attachment 0002 – AI Use Compliance and Risk Management Plan

The Centers for Disease Control and Prevention (CDC) is seeking a contractor to conduct a multi-jurisdictional formative research study supporting the expansion of self-collection-based viral load monitoring for the Ending the HIV Epidemic initiative. This will be a firm-fixed-price purchase order, with the period of performance from August 1, 2026, to July 31, 2027. Services are to be performed at the contractor’s facility. The applicable NAICS code is 541720 (Research and Development in the Social Sciences and Humanities), and the procurement is unrestricted. Quoters must be registered in the System for Award Management (SAM) to be eligible for award.